Literature DB >> 3544629

Detection of malignant melanoma of the uterine cervix from Papanicolaou smears. A case report.

H C Yu, M Ketabchi.   

Abstract

A case of malignant amelanotic melanoma of the uterine cervix in a patient presenting with right hemiparesis and enlarged lymph nodes was diagnosed in Papanicolaou-stained cervical smears showing many melanoma cells. Melanoma cells with bizzare nuclear and cytoplasmic abnormalities, rarely seen in other tumors, helped to establish a positive diagnosis. The diagnosis was confirmed by histopathologic study of the endocervical surgical specimen, including a positive immunoperoxidase staining for S-100 protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3544629

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  5 in total

1.  Primary amelanotic melanoma of the cervix: case report with review of literature.

Authors:  Rajan Duggal; Radhika Srinivasan
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

Review 2.  Primary malignant melanoma of esophagus: a case report and review of literature.

Authors:  Yue-Ming Hu; Ji-Dong Yan; Yang Gao; Qing-An Xia; Yu Wu; Zhi-Yong Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

3.  Coexisting malignant melanoma and blue nevus of the uterine cervix: an unusual combination.

Authors:  David Parada; Karla B Peña; Frances Riu
Journal:  Case Rep Pathol       Date:  2012-09-16

4.  Cytomorphology of cervicovaginal melanoma: ThinPrep versus conventional Papanicolaou tests.

Authors:  Namrata Setia; Robert A Goulart; Gladywn Leiman; Christopher N Otis; Rukmini Modem; Liron Pantanowtiz
Journal:  Cytojournal       Date:  2010-12-31       Impact factor: 2.091

5.  Primary Malignant Melanoma of the Cervix: An Integrated Analysis of Case Reports and Series.

Authors:  Aiping Min; Aizhen Fu; Meiyuan Huang; Hongjing Wang; Huan Chen
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.